Announcements Trials
Browse Landscape

Phase

Phase 1/2 14Phase NA 7Phase 2 7Phase 1 5Phase 3 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Renal Insufficiency, Chronic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 4Sirolimus 2Magnetic Resonance Spectroscopy 2Etoposide 2venetoclax 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1daratumumab 1copanlisib 1alovudine 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Transplantation Conditioning 1Transplantation 1Stem Cell Transplantation 1Spinal Puncture 1Specimen Handling 1Pneumococcal Vaccines 1Photopheresis 1Phantoms, Imaging 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Mycophenolic Acid 1Methotrexate 1Mesna 1Mesenchymal Stem Cell Transplantation 1Leukapheresis 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × venetoclax × Clear all
NCT05386576 2025-06-15

A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
12 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡